This site is intended for healthcare professionals only
LoginRegister
Biocon Secures USFDA Nod for Generic Liraglutide Prefilled Pens for DiabetesBiocon Biologics Bengaluru facility gets 5 USFDA observations
Gujarat Pharma Group Under GST Scanner for Rs 115 Cr Bogus Billing, Two HeldThese 33 Life-Saving Drugs, Including Daratumumab, Alectinib, Obinutuzumab, Now GST-Free, See List
Andhra Drug Inspector, Aide Caught Red-Handed Accepting Rs 20,000 BribeVigilance Nabs Drugs Inspector Taking Rs 40,000 Bribe for Pharmacy Licence
Govt Amends UCPMP 2024: CEOs Must Disclose Marketing Expenses, Free Sample Pricing Norms FinalizedGovt Amends UCPMP 2024: CEOs Must Disclose Marketing Expenses, Free Sample Pricing Norms Finalized
ZydusZydus, Synthon enter licensing, supply agreement for multiple sclerosis drug Ozanimod for US market
CDSCO Panel Seeks More Clinical Data from Regenix Drugs on rDNA-Based Insulin InjectionNovo Nordisk to Discontinue Multiple rDNA Insulin Products in India
Maha: Direct Second-Year B.Pharm Admissions via Diploma Route Surge 60% in 2 Years, Reach 14,010 in 2025-26Maha: Direct Second-Year B.Pharm Admissions via Diploma Route Surge 60% in 2 Years, Reach 14,010 in...
Delhi HC Bars Dr Reddys from Selling Olymviq Over Similarity with Novo Nordisks OzempicPiramal Gets Delhi HC Relief, Decades-Old Spurious Tixylix Cough Syrup Case Quashed
Novartis to Acquire Excellergy in USD 2 Billion Deal to Boost Food Allergy PipelineNovartis, Argo Biopharma expand strategic alliance with USD 5.2 billion Cardiovascular drugs deal
GE HealthCare gets CE Mark for new StarGuide GX systemGE HealthCare Revolution Vibe CT system gets USFDA clearance
Shilpa Biologicals, Stein Cares Ink Exclusive Biosimilar Licensing Pact for Latin AmericaNovartis, Arrowhead strike upto USD 2 billion deal for neuromuscular therapy license
Eli Lilly appoints Vivek Jha as Sr DirectorEli Lilly appoints Vivek Jha as Sr Director - Commercial Strategy, AI & Transformation within the...
X